ARTICLE | Company News
Biopharmaceutics deal
October 3, 1994 7:00 AM UTC
The Bellport, N.Y., company acquired from the Research Foundation of State University of New York at Stony Brook the rights to an antiviral compound that kills HIV and hepatitis B viruses. The compoun...